Status:
COMPLETED
Open Versus Endovascular Revascularization in Patients With End-stage Renal Disease
Lead Sponsor:
University Hospital Erlangen
Conditions:
End-stage Renal Disease
Critical Limb Ischemia
Eligibility:
All Genders
Brief Summary
Treatment of patients with end-stage renal disease and critical limb ischemia still poses challenges to vascular medicine due to limited survival, comorbidities and infrapopliteal involvement of arter...
Detailed Description
Query of internal clinical database for identification of patients (2009-2017)with end-stage renal disease and critical limb ischemia, receiving either open surgical (Group I "OR") or endovascular rev...
Eligibility Criteria
Inclusion
- presence of end-stage renal disease
- presence of critical limb ischemia (Ankle-brachial-index \> 0.4 or presence of rest pain or ischemic ulcers or gangrene)
- revascularisation by means of Bypass or endovascular therapy
Exclusion
- conservative Treatment
- non-atherosclerotic lesions
- coagulation disorders
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2017
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT03293589
Start Date
July 1 2017
End Date
October 30 2017
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Erlangen, Bavaria, Germany, 91054